- Home
- IPHA vs TWIN Comparison
IPHA vs TWIN Comparison
Compare IPHA & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- TWIN
- Stock Information
- Founded
- IPHA 1999
- TWIN 1918
- Country
- IPHA France
- TWIN United States
- Employees
- IPHA N/A
- TWIN N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- TWIN Industrial Machinery/Components
- Sector
- IPHA Health Care
- TWIN Industrials
- Exchange
- IPHA Nasdaq
- TWIN Nasdaq
- Market Cap
- IPHA 160.1M
- TWIN 97.0M
- IPO Year
- IPHA 2019
- TWIN N/A
- Fundamental
- Price
- IPHA N/A
- TWIN $9.68
- Analyst Decision
- IPHA Strong Buy
- TWIN Strong Buy
- Analyst Count
- IPHA 1
- TWIN 1
- Target Price
- IPHA $11.00
- TWIN $12.00
- AVG Volume (30 Days)
- IPHA 11.7K
- TWIN 157.2K
- Earning Date
- IPHA 03-27-2025
- TWIN 08-14-2025
- Dividend Yield
- IPHA N/A
- TWIN 1.65%
- EPS Growth
- IPHA N/A
- TWIN N/A
- EPS
- IPHA N/A
- TWIN 0.29
- Revenue
- IPHA $20,831,349.00
- TWIN $328,478,000.00
- Revenue This Year
- IPHA $209.83
- TWIN $27.91
- Revenue Next Year
- IPHA $83.15
- TWIN N/A
- P/E Ratio
- IPHA N/A
- TWIN $33.23
- Revenue Growth
- IPHA N/A
- TWIN 11.49
- 52 Week Low
- IPHA $1.29
- TWIN $6.16
- 52 Week High
- IPHA $3.51
- TWIN $14.98
- Technical
- Relative Strength Index (RSI)
- IPHA 39.24
- TWIN 71.95
- Support Level
- IPHA $1.71
- TWIN $8.67
- Resistance Level
- IPHA $1.92
- TWIN $9.88
- Average True Range (ATR)
- IPHA 0.09
- TWIN 0.54
- MACD
- IPHA -0.00
- TWIN 0.13
- Stochastic Oscillator
- IPHA 37.93
- TWIN 87.14
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.